Allworth Financial’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$244 Sell
125
-1,116
-90% -$2.3K ﹤0.01% 5194
2026
Q2
$2.02K Buy
1,241
+767
+162% +$1.06K ﹤0.01% 4515
2026
Q1
$536 Buy
+474
New +$675 ﹤0.01% 4718

Other funds holding INMB

Allworth Financial's INMB Position: Q3 2026 in Review

Allworth Financial reduced its INmune Bio (INMB) stake by 90% in Q3 2026, selling an estimated $2.3K and leaving 125 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #5194.

Allworth Financial first reported a position in INMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.02K in Q2 2026. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Allworth Financial held 125 shares of INmune Bio worth $244 as of Q3 2026.
  • Allworth Financial sold 1,116 INmune Bio shares in Q3 2026, an estimated $2.3K.
  • INmune Bio made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5194 holding.
  • Allworth Financial first reported a position in INmune Bio in Q1 2026 and has held it in 3 quarters since.
  • Allworth Financial's INmune Bio position peaked at $2.02K in Q2 2026.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.